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A B S T R A C T
Purpose: To study the clinical outcome in hippocampal deep brain stimulation (DBS) for the treatment of
patients with refractory mesial temporal lobe epilepsy (MTLE) according to the electrode location.
Methods: Eight MTLE patients implanted in the hippocampus and stimulated with high-frequency DBS
were included in this study. Five underwent invasive recordings with depth electrodes to localize ictal
onset zone prior to chronic DBS. Position of the active contacts of the electrode was calculated on
postoperative imaging. The distances to the ictal onset zone were measured as well as atlas-based
hippocampus structures impacted by stimulation were identiﬁed. Both were correlated with seizure
frequency reduction.
Results: The distances between active electrode location and estimated ictal onset zone were 11  4.3 or
9.1  2.3 mm for patients with a >50% or <50% reduction in seizure frequency. In patients (N = 6) showing a
>50% seizure frequency reduction, 100% had the active contacts located <3 mm from the subiculum
(p < 0.05). The 2 non-responders patients were stimulated on contacts located >3 mm to the subiculum.
Conclusion: Decrease of epileptogenic activity induced by hippocampal DBS in refractory MTLE: (1)
seems not directly associated with the vicinity of active electrode to the ictal focus determined by
invasive recordings; (2) might be obtained through the neuromodulation of the subiculum.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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Epilepsy is a frequent neurological disease that affects 0.5–1% of
the population.1 About 30% of patients have a pharmacologically
intractable form of epilepsy.2 Mesial temporal lobe epilepsy
(MTLE) is a particularly common form of pharmacoresistant
epilepsy.3 Surgical resection of the amygdalo-hippocampal struc-
tures alone or together with the anterior portion of temporal lobe is
an effective treatment of MTLE.4,5 However, ablative surgery is not
possible in up to 30% of patients in whom resection of the
amygdalo-hippocampal complex will result in severe neurological
impairments such as memory deﬁcits,2,6 or in cases involving
bitemporal epileptic foci. In these patients electrical stimulation of
the amygdala and hippocampus has been proposed as an
alternative treatment.7–10* Corresponding author at: Department of Neurosurgery, University Hospital
Bern, CH-3010 Bern, Switzerland. Tel.: +41 031 632 08 10; fax: +41 031 382 24 14.
E-mail address: claudio.pollo@insel.ch (C. Pollo).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.02.007Previous studies have highlighted the efﬁcacy of high frequency
deep brain stimulation (DBS) to reduce epileptic activity either by
targeting intracerebral structures believed to have a triggering role
in the epileptic network, such as the thalamus, the subthalamic
nucleus, the caudate nucleus, and the cerebellum or the vagal
nerve.11–13 Alternatively, the ictal onset zone may be targeted,
with the hypothesis that stimulation may interfere with seizure
initiation. The latter strategy has been described to be suitable to
control seizures in patients with MTLE. In these cases investiga-
tions using intracranial electrodes14,15 have strongly suggested
that seizure onset and propagation involve the amygdala and
hippocampus.
Clinically, it has been shown that hippocampal stimulation
using depth electrodes signiﬁcantly reduces interictal EEG
spikes16,17 and improves seizure outcome in patients with
temporal lobe epilepsy.7–10,16,18,19 However, responses are variable
in terms of seizure frequency reduction leading to the need for a
better understanding of the mechanism by which DBS reduces
seizure frequency, as well as identiﬁcation of optimal targets and
optimization of stimulation parameters. One hypothesis is that
DBS may act through local inhibition of neurons adjacent to thevier Ltd. All rights reserved.
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cerebral structures triggering seizure onset. Alternatively, DBS
may have an effect on the network of neuronal projections
connecting several cerebral structures.20 Since mesial temporal
lobe structures are potentially involved in epileptic networks, the
targeting of ictal foci in this region may also affect adjacent
networks.
We previously published a study that focused on the efﬁciency
of hippocampal stimulation on reducing seizure frequency and on
the inﬂuence of stimulation parameters. One unresolved issue
concerns the impact of electrode positioning on seizure treatment,
which may in turn prove informative for targeting practices in
general.
Therefore, in the present study, we retrospectively analyzed (1)
the distance between the implanted DBS stimulating contact(s)
relative to the ictal onset focus determined invasively, and (2) the
anatomical structures possibly inﬂuenced by electrical stimula-
tion. These two parameters were compared with the clinical
outcome.
2. Methods
2.1. Patients and inclusion criteria
Eight patients with intractable MTLE epilepsy were selected for
DBS treatment between June 2002 and April 2008 as previously
described10 (5 women and 3 men, median age: 31.5 years, range:
25–47). The criteria for patient selection to proceed with DBS
included pharmaco-resistance and proven MTLE seizure origin.
Resective surgery is usually proposed as the treatment of choice in
these patients. DBS was considered in patients with either
concerns for possible post-operative signiﬁcant worsening of
memory, particularly verbal memory, or when bilateral epilepto-
genic zones were suspected. Details of inclusion criteria and of the
presurgical protocol were published previously10 and include
high-resolution brain MRI, video-EEG telemetry, interictal positron
emission tomography (PET), ictal and interictal single photon
emission computerized tomography (SPECT), as well as neuropsy-
chological and psychiatric examinations. High-resolution MRI
showed a hippocampal sclerosis in 2 patients; the remaining 6 had
non-lesional MTLE (Table 1).
The study was approved by the local Ethics Committee of the
University Hospitals of Geneva and Lausanne, and an informed
consent was obtained from each patient.
2.2. Identiﬁcation of ictal focus
In 5 of 8 patients (Pt4, 5, 7, 8, 9), the EEG ictal onset focus was
estimated by invasive recordings using intracerebral depthTable 1
Clinical characteristics of patients.
Patient Sex Age/onset Follow-up
(months)
HS Side Ictal focu
Pt1 F 37/24 74 Yes Left – 
Pt2 F 32/3 50 Yes Right – 
Pt3 F 44/4 46 No Right – 
Pt4 F 31/25 45 No Left LAH1-2 
Pt5 M 47/21 42 No Right RAH3 
Pt7 M 31/14 34 No Left LAH2 
Pt8 M 25/13 11 No Left LA1a
Pt9 F 26/13 10 No Left LAH2 
HS: hippocampal sclerosis, quad: quadripolar stimulation, LAH: left anterior hippocamp
stimulated, C: electrode contact.
a Secondary focus.electrodes inserted perpendicular to the skull surface at amygda-
lar, anterior and posterior hippocampal levels in both temporal
lobes as previously described.10 Epileptogenic ictal focus was
assigned to the contact (numbered 1 to 8) recording maximal ictal
activity (pathological waveform). A high-resolution CT scan was
then co-registered with a T1-weighted MRI acquired under
stereotactic conditions (CRW, Radionics1, Burlington, MA, USA)
and processed using the Framelink 5.1 software on a Stealth
workstation (Medtronic Inc, Minneapolis, MN, USA). The postop-
erative imaging was realigned to the anterior commissure-
posterior commissure (AC–PC) coordinates system by identifying
the anterior and posterior commissures and 3 midline landmarks.
Origin was set at the midcommissural point. Three orthogonal
planes of view were then used to localize the electrode contact. Its
coordinates were calculated and expressed as (x) mm lateral to the
midline, (y) mm antero-posterior and (z) mm supero-inferior to the
mid-commissural plane.
2.3. Surgical procedure
Surgical planning and procedure were performed as previously
described.10 The Pisces-Quad 3487A electrode and the Soletra
7426 stimulator (Medtronic Inc, Minneapolis, MN, USA) were
implanted in the ﬁrst 5 patients. The 4 cylinder-shaped contacts of
the Pisces-Quad electrode are 3 mm in length and 1.27 mm in
diameter. The intercontact distance is 6 mm, and the electrode is
30 mm in total length. The 3 remaining patients received the Sub
Compact Octad 3876 electrode and the Restore stimulator
(Medtronic Inc., Minneapolis, MN, USA). The Sub Compact Octad
electrode is 34.5 mm in total length with 8 contacts (3 mm length,
1.27 mm diameter, 1.5 mm intercontact distance). The DBS
electrodes were placed parasagittaly in the amygdalo-hippocam-
pal complex so that the distal contact (contact 0) could be
implanted in the area of the amygdala. Internalization of the
electrode and connection to the neurostimulator was performed
3–4 days after the implantation procedure to provide EEG
recordings.
2.4. Stimulation parameters and follow-up
The setting of post-implantation stimulation parameters and
neurological evaluations were performed as previously de-
scribed.10 All patients were stimulated at high-frequency, i.e.
130 Hz, and with pulse width of 0.45 ms. The amplitude of
stimulation (0.5–2 V) and the number of contacts stimulated (bi-
or quadripolar) were, however, different across patients. In the
quadripolar conﬁguration, the 4 contacts were set as cathodes, and
the case box of the neurostimulator was set as the anode. In the
bipolar conﬁguration, the cathode was set on the contacts Interictal
focus
Stimulation
contact
Amplitude
(V)
Outcome (% reduction
in seizure frequency)
C1 quad 1 67
C2 quad 1 88
C0 quad 0.5 72
C1 C0–C1 0.5 84
n.i. C0–C1 1 100
C2 C1–C2 1 0
C2–C3 1 0
C2 C1–C2 1.5 22
C0 off 0 100
C4 off 0 100
us, RAH: right anterior hippocampus, n.i.: not identiﬁed, LA: left amygdala, off: not
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determined from intracranial EEG recordings before the internali-
zation of the neurostimulator, and the anode was set on the contact
closest to the second major interictal epileptogenic site. After a 3
month off-period, patients were followed for a median duration of
43.5 months (range 10–74 months). Quantiﬁcation of the clinical
outcome and efﬁcacy of stimulation was performed by the
evaluation of the ratio between the improvement in seizure
frequency after implantation compared to pre-implantation
baselines determined prospectively as the mean number of
seizures per month during the three months prior to implantation
(according to patients’ self-reports). Introduction of any new AED
was not allowed after implantation in order to determine the effect
of DBS, but minor changes in medication dosages were accepted as
previously described.10 Characteristics of patients, stimulation
parameters and clinical outcome are summarized in Table 1. For
the following analysis, patients were then split into 2 groups
according to their rate of seizure frequency reduction (i.e. > or
=50% and <50%).
2.5. Determination of the distance between the active contact(s) of the
DBS electrode and the estimated ictal focus
Postoperative imaging was processed using the Framelink 5.1
software on a Stealth workstation (Medtronic Inc, Minneapolis,
MN, USA) and realigned to the AC–PC coordinates system with
origin set at the midcommissural point. The electrode contact
image artifact was localized in the 3 orthogonal planes of view. The
center of the artifact was identiﬁed as the center of the electrode
(Fig. 1A) according to a previous study of DBS in patients with
Parkinson’s disease.21 Its coordinates (x), (y) and (z) were
calculated as explained above. In 5 patients, AC–PC coordinates
were subtracted in each plane (dx, dy, dz) to determine the distance
between the estimated ictal focus and the implanted electrode
contacts. Euclidian distance in 3D space was then calculated
(square root of (dx2 + dy2 + dz2)). These 4 parameters, as well as
clinical outcome, were used for further analysis. In each case,
distances between the estimated ictal focus and all contacts of theFig. 1. MRI analysis using the surgical navigation system Stealth workstation (Medtronic
post-operative brain T1-weighted MRI of Pt3 treated with DBS, enabling determination o
the scan to the AC–PC line is shown in the coronal plane. The white asterisk indicates the
regions with superimposed standard neuro-anatomical atlas (adapted from Mai JK, Asshe
white 3 mm-radius circle reﬂects the brain area supposed to be inﬂuenced by the electro
dentata; opt, optic tract; TLV, temporal horn of lateral ventricle; PaS, parasubiculum; Pelectrode were calculated in order to estimate the minimal
distance to the electrode.
2.6. Determination of structures in the vicinity of the electrodes
inﬂuenced by DBS
To identify structures in the vicinity of active electrode contacts,
postoperative imaging was co-registered and adjusted with the
corresponding template of a neuro-anatomical atlas22 prepared
according to the Talairach standard transformation23 (Fig. 1B).
Structures overlapping a 3 mm-radius circle centered on the
artifact of the electrode contact were considered as possibly
inﬂuenced by electrical stimulation (Fig. 1C), according to the
estimation of the volume of tissue activated taken from different
existing ﬁnite element models of electrical propagation around the
electrode.24,25 The nonparametric Spearman correlation test was
used for the statistical analysis on small samples.
3. Results
3.1. Clinical outcome and stimulation parameters
Postoperative seizure frequencies were compared with a pre-
implantation baseline period. Six of the 8 patients exhibited a
reduction of seizure frequency of >50%, including 2 seizure-free
patients (i.e. 100% reduction of seizure frequency). The 2 remaining
patients were non-responders (i.e. no signiﬁcant change in seizure
frequency). Reasons that could explain such good results compared
to other studies have been previously discussed.10 In the ﬁrst
group, Pt1 and Pt2 did not show any reduction when stimulated in
a bipolar conﬁguration with contacts C0 and C1. When stimulated
in a quadripolar conﬁguration, they experienced a signiﬁcant
reduction in seizure frequency (67% and 88%, respectively) as
published previously.10 Pt3 and Pt4 also showed a major seizure
reduction of 72% and 84% with the quadripolar and bipolar
conﬁguration, respectively. Pt5 and Pt9 became seizure free with a
bipolar conﬁguration; the latter remained seizure free after the
electrode was implanted, and during the off-period without Inc., Minneapolis, MN, USA). (A) Measurement of electrode contact (C1) position on
f stereotactic coordinates based upon the stereotactic surgical frame. Realignment of
 center of the DBS electrode contact. (B) Overview of the hippocampal and subicular
uer J, Paxinos G. Atlas of the human brain. San Diego: Academic Press; 1998). (C) The
de contact. CA, cornu ammonis; DG, dentate gyrus; Ent, entorhinal cortex; FD, fascia
rS, presubiculum; S, subiculum.
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seizure frequencies during bipolar stimulation. Findings regarding
Pt7 were previously reported and indicated a seizure reduction
during the ﬁrst 6 months, but unfortunately the electrode had to be
reimplanted due to a fracture of the ﬁrst Pisces Quad electrode.
With the new Sub Compact Octad electrode, no seizure reduction
was achieved during the months of bipolar stimulation at 1 V. The
follow-up for each patient is indicated in Table 1. The outcome was
not correlated to the follow-up (Spearman test, r = 0.0599, n.s.).
3.2. Distance of active contact to estimated ictal focus
The ictal focus was estimated in the 5 investigated patients with
invasive recordings. Since Pt9 was seizure-free even without
stimulation, distances of the estimated ictal focus to the contacts
were not considered for the analysis. For the 4 remaining patients,
the Euclidian distances between the location of electrode contacts
used for stimulation and the contacts registering maximal ictal
activity during pre-surgical invasive investigations were all greater
than 6 mm (see Table 2). These values ranged from 1.6 to 7.8 mm in
the latero-medial (x) axis, from 0.7 to 14.8 mm in the antero-
posterior (y) axis, and from 0.8 to 7.0 mm in the supero-inferior (z)
axis. The mean Euclidian distances are 11.0  4.3 or 9.1  2.3 mm
for patients with a >50% or <50% reduction in seizure frequency,
respectively. No relation could be observed between the distance of
active electrode contacts to the estimated ictal focus and clinical
outcome. Interestingly, the entire electrode of Pt9 is localized far from
the estimated ictal focus (>10 mm).
3.3. Identiﬁcation of cerebral structures impacted by electrode
stimulation
In order to further characterize mechanisms underlying DBS
effect on seizure frequency reduction, the amygdalo-hippocampal
areas stimulated by the electrodes were identiﬁed on coronal MRI-
slices. Most of the active electrode contacts are localized close to
the CA1 ﬁeld of the hippocampus and the subiculum (Table 3). In
patients showing a >50% seizure frequency reduction, 100% had
their subiculum localized at less than 3 mm from the active
contacts. Pt7 and Pt8 presented no signiﬁcant reductions in seizure
frequency and were not stimulated in an area including the
subiculum. The clinical outcome was signiﬁcantly correlated with
the proximity of the subiculum to the closest active contactTable 2
Distances from electrode contacts to estimated ictal focus.
Patient Stimulated
contact
Distance (mm)
dx dy dz 3D
Pt4 C0+ 7.7 6.9 3.9 11.1
C1 7.2 1.8 0.8 7.5
Pt5 C0 4.6 14.8 7.0 17.0
C1+ 1.6 6.7 5.0 8.5
Pt7 C1+ 4.2 8.2 6.2 11.1
C2 4.8 2.7 4.2 7.0
C3+ 5.0 0.8 3.5 6.1
Pt8 C1+ 7.6 0.7 6.7 10.1
C2 7.8 3.6 6.9 11.0
Pt9 C0 6.7 13.0 0.5 14.6
C1 8.2 7.9 1.3 11.4
C2 9.4 4.5 2.4 10.7
C3 11.2 0.1 3.8 11.8
C4 12.6 4.7 5.4 14.5
C5 13.3 8.2 6.0 16.7
C6 14.8 12.0 7.0 20.3
C7 15.9 16.7 8.5 24.6
+,: Polarity of the stimulated contacts.
3D: Euclidian distance.(Spearman test, r = 0.677, p < 0.05). On the other hand, all patients
had their active contacts close to the CA1 ﬁeld of the hippocampus,
including the two non-responders, and no correlation was
observed (r = 0.5668, n.s.). Furthermore, as described above,
Pt1 and Pt2 showed better outcomes when stimulated in a
quadripolar conﬁguration including the contact C2, the nearest
contact to the subiculum.
4. Discussion
DBS has been shown to be successful in the treatment of
refractory epilepsy, despite the wide spectrum of results produced
in clinical experiences in the literature. Pioneering studies
concerning hippocampal stimulation for MTLE are based on small
patient populations.8,9,18,19 Its mechanisms of action remain
largely unknown. In the present study we ﬁrst examined the
relationship between electrode contacts and estimated ictal onset
zone locations to further investigate its impact on clinical outcome
in MTLE. We did not observe any clear relationship between the
location of active contacts and the presumed ictal onset focus. DBS
active electrode contacts were all found to be positioned more than
6 mm from the estimated ictal onset focus. The accuracy of ictal
onset focus localization by invasive recordings may be questioned,
especially in the antero-posterior direction where the sampling
with depth electrodes was performed in the range of 1 cm, and as
the recorded EEG (local ﬁeld potentials) is supposed to reﬂect the
synchronous activity of numerous neurons.26 However, it is
reasonable to think that the error in the antero-posterior direction
should not exceed the range of 5 mm (i.e. half the distance between
two electrodes). Moreover, as the mean Euclidian distance
between the ictal focus and the stimulated contacts for patients
with a >50% or <50% reduction in seizure frequency are
comparable, and calculated with the same probability of error,
we suggest that the seizure outcome is not directly related to the
vicinity of the ictal focus determined with invasive electrodes. As
an illustrative example, Pt9 showed a good outcome without
stimulation (probably due to a micro-lesional effect). Since the
entire electrode of Pt9 is localized >10.6 mm from the estimated
ictal focus, it seems difﬁcult to associate this outcome through a
direct effect on the ictal focus.
Due to the small number of patients it was difﬁcult to perform
statistical analyses, but no trend seems to separate one group from
the other in any axis, or according to patients’ characteristics
(presurgical seizure frequency, type of seizure, hippocampal
sclerosis). However, considering that the current spread from
the electrode is presumed to be smaller than 4 mm in radius
according to DBS models, we observed that sufﬁcient reduction in
seizure frequency was obtained even when the contacts were
localized at higher distances. This suggests that indirect effects
could be produced by stimulation of a particular structure, or part
of it, potentially involved in the onset or propagation of the
epileptic current of mesio-temporal seizure. In our experience,
patients with hippocampal sclerosis generally needed a more
extended area of stimulation and had more electrode contacts
stimulated, compared to the non-lesional cases. Although we do
not have a deﬁnitive explanation, one speculation is that
morphological changes induced by sclerosis may result in less
functional tissue that can be stimulated and/or in an increase in
tissue impedance.
Interestingly, the contacts presenting maximal ictal activity
during presurgical invasive recordings were the contacts closest to
the subiculum in 3 of 5 patients. Due to the spatial resolution,26 it is
not possible to exclude that ictal activity of other structures could
be nonetheless recorded at these sites. Therefore, caution should
be taken before drawing conclusions regarding the possible role of
the subiculum in generation or in propagation of epileptic currents.
Table 3
Structures localized near the stimulated contacts.
Patient Stimulated
contact
LaV LaI LaDA BM BL BLVM BLI HiH DG CA3 CA2 CA1 S PrS Ent PHG TLV
Pt1 C0 +++ ++ ++ +
C1 +++ ++ +
C2 +++ + ++
C3 +++ +++ +++
Pt2 C0 ++ ++ + +
C1 +++ + +
C2 ++ + +++ +
C3 ++ + ++
Pt3 C0 ++ ++ ++
C1 +++ +++ ++
C2 + + +++
C3 ++ + + +++ + +
Pt4 C0 ++ ++ ++
C1 +++ ++ +
Pt5 C0 +++ + ++
C1 + +++ ++
Pt9 C0 +++ ++
C1 +++ +
C2 ++ +++ ++ ++
C3 + ++
C4 +++ +++ + ++
C5 +++ + ++
C6 +++ +++ ++ ++
C7 +++ ++ +++
Pt7 C1 ++ +++
C2 ++ +++ + +
C3 ++ ++ +
Pt8 C1 + + + +++
C2 +++
Patients with a >50% reduction in seizure frequency are grouped in the upper part of the table and indicated in bold type. The proximity of the subiculum to the stimulated
contacts is also indicated in bold type. + to +++: proportion of the structure localized in a 3 mm-radius area around the electrode contact. BL: basolateral amygdaloid nucleus,
BLI: basolateral amygdaloid nucleus intermediate part, BLVM: basolateral amygdaloid nucleus ventromedial part, BM: basomedial amygdaloid nucleus, CA1: CA1 ﬁeld of the
hippocampus, CA2: CA2 ﬁeld of the hippocampus, CA3: CA3 ﬁeld of the hippocampus, DG: dentate gyrus, Ent: entorhinal cortex, HiH: hippocampal head, LaDA: lateral amygd.
nucl. dorsal anterior part, LaI: lat. amygdaloid nucl. intermed. part, LaV: lateral amygdaloid nucl. ventral part, PHG: parahippocampal gyrus, PrS: presubiculum, S: subiculum,
TLV: temporal horn of lateral ventricle.
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tures located within a 3 mm-radius sphere around the active
contacts of stimulation showed that all patients were well-
stimulated in the CA region of the hippocampus. Interestingly, the
electrode contacts that were closer to the subiculum, or may have
had a lesional effect on the subiculum during the electrode
insertion, were associated with important reductions in seizure
frequency, whereas no signiﬁcant effect was observed when the
electrode was located farther than 3 mm from the subiculum. This
observation suggests that the efﬁcacy of DBS might be associated
with the involvement of the subiculum, which also carries axons of
the perforant pathway, and that the beneﬁcial effects may be
obtained through neuromodulation of this structure.
Several studies have highlighted the role of the dentate gyrus
and CA1 region in hippocampal sclerosis models.27,28 More
recently, several studies29–33 have demonstrated that the sub-
iculum and parahippocampal structures, but not the hippocampus
itself, play an active role in the generation and propagation of
temporal lobe seizures, even in non-sclerotic hippocampal
tissues.34 Our study is the ﬁrst to provide clinical data in humans
supporting a potential involvement of the subiculum in the
generation and/or propagation of seizures in MTLE.
There are no data underlying the direct neuromodulatory effect
of electrical stimulation on the subiculum in refractory MTLE.
Studies have suggested that changes in GABAergic signaling
causing (1) hyperexcitability in the subiculum, that recalls the
GABAergic excitation29,35 of early development, as well as (2) thevulnerability of GABAergic interneurons, that may give rise to an
input-speciﬁc impairment of inhibition,32 are the mechanisms
underlying development of MTLE at a cellular level. According to
these observations, neuromodulatory effects of high-frequency
DBS may decrease the excitability of the subiculum and then
improve the inhibitory effect of GABAergic pathways on genera-
tion and/or propagation of MTLE.
The reliability of our results could be improved by increasing
the series size, especially when subgroups are considered. Further
prospective multicentric studies involving a greater number of
patients are necessary to provide more consistent data conﬁrming
the role of the subiculum in electrical stimulation in refractory
MTLE.
In conclusion, our results suggest that decreases of epilepto-
genic activity induced by hippocampal high frequency DBS in
refractory MTLE seem not to be associated with the vicinity of
the active electrode to the ictal focus determined by invasive
recordings. Instead, they might be associated with the vicinity of
the active electrode to the subiculum and obtained through the
neuromodulation of this structure. Further prospective studies
conducted on a larger group of patients are necessary to conﬁrm
the neuromodulatory effect of hippocampal DBS on the
subiculum.
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